| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 08/08/2002 | WO2002000885A3 Assembly of wild-type and chimeric influenza virus-like particles (vlps) |
| 08/08/2002 | WO2002000840A3 Human lyases |
| 08/08/2002 | WO2001098455A3 Method for preparing a physiologically active il-18 polypeptide |
| 08/08/2002 | WO2001096546A3 Protein phosphatases |
| 08/08/2002 | WO2001096393A3 Nucleotide and amino acid sequences of oocyte factors for altering ovarian follicular growth in vivo or in vitro |
| 08/08/2002 | WO2001090330A3 AMINOACYL tRNA SYNTHETASES |
| 08/08/2002 | WO2001085926A3 Nucleotide sequences involved in increasing or decreasing mammalian ovulation rate |
| 08/08/2002 | WO2001034802A9 Compositions and methods for the therapy and diagnosis of prostate cancer |
| 08/08/2002 | WO2001021799A9 Traf4 associated cell cycle proteins, compositions and methods of use |
| 08/08/2002 | WO2001013714A3 Prostatic cell line and animal model of a prostatic tumor |
| 08/08/2002 | WO2001009328A9 15571, a novel gpcr-like molecule of the secretin-like family and uses thereof |
| 08/08/2002 | US20020107869 Novel implant and novel vector for the treatment of acquired diseases |
| 08/08/2002 | US20020107385 Human breast tumor-specific proteins |
| 08/08/2002 | US20020107372 Nucleotide sequences coding membrane protein for use in the treatment of inflammation,lung defects and viral diseases |
| 08/08/2002 | US20020107370 Protein for use in the treatment of lzheimer's, parkinson's, amyotrophic lateral sclerosis, multiple sclerosis, retinopathy, brain, blood, myocardium, stroke, reperfusion injury and liver disorders |
| 08/08/2002 | US20020107366 Polypeptide for use in the treatment of mammalian viral diseases |
| 08/08/2002 | US20020107365 Ligands for flt3 receptors |
| 08/08/2002 | US20020107363 B7-Like molecules and uses thereof |
| 08/08/2002 | US20020107362 Novel fluorescent proteins |
| 08/08/2002 | US20020107361 Novel metalloproteases having thrombospondin domains and nucleic acid compositions encoding the same |
| 08/08/2002 | US20020107360 Hepatitis E virus antigens and uses therefor |
| 08/08/2002 | US20020107194 Able to bind to a Notch protein forming Delta-Notch complex |
| 08/08/2002 | US20020107180 Cell surface glycoproteins |
| 08/08/2002 | US20020106780 Extracellular matrix polynucleotides, polypeptides, and antibodies |
| 08/08/2002 | US20020106778 Human PTTG polypeptide and method for producing it |
| 08/08/2002 | US20020106777 Human PEC-60-like protein and DNA encoding this protein |
| 08/08/2002 | US20020106743 IL-17 homologous polypeptides and therapeutic uses thereof |
| 08/08/2002 | US20020106742 Nucleic acids encoding active and inactive CCR5 chemokine receptors |
| 08/08/2002 | US20020106731 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of apoptosis and inflammation defects |
| 08/08/2002 | US20020106729 Nucleotide sequences for use as tools in genetic engineering |
| 08/08/2002 | US20020106728 NS4 nucleic acids and polypeptides and methods of use for the treatment of body weight disorders |
| 08/08/2002 | US20020106726 Peptide for use in the treatment of inflammation defects |
| 08/08/2002 | US20020106725 Generating preferential enzymatic polypeptide for use in foods, animal feed, pharmacology, and dentistry |
| 08/08/2002 | US20020106724 RNA-binding protein |
| 08/08/2002 | US20020106723 Receptor for latrotoxin from insects |
| 08/08/2002 | US20020106719 Generation of preferential proteins in cell free system; obtain cell extract, incubate with nucleotide sequences, expose to translational organelles, recover processed proteins |
| 08/08/2002 | US20020106680 Joining preferential nucleotide sequences; generate solid phase, incubate with nucleotide sequences, remove nucleotide sequence which have protrusions from terminals, recover bound nucleotide sequences |
| 08/08/2002 | US20020106671 Identification of a capacitative calcium channel in antigen presenting cells and uses thereof |
| 08/08/2002 | US20020106669 Enzymatic polypeptide for use as tool in amplifying energy efficiency in bacteria |
| 08/08/2002 | US20020106655 Nucleotide sequences coding preferential protein for use in the treatment, diagnosis and prevention of immunological, nervous system and tumor disorders |
| 08/08/2002 | US20020106650 Nucleotide sequence coding preferential polypeptide; for use in the treatment, prevention and diagnosis of kidney, liver, reproductive and cardiovascular disorders |
| 08/08/2002 | US20020106639 Postweaning multisystemic wasting syndrome virus from pigs |
| 08/08/2002 | US20020106636 Monoclonal antibodies to human immunodeficiency virus and uses thereof |
| 08/08/2002 | US20020106629 Genetically engineering preferential immunoglobulins in cells; obtain cells, transform with vector containing genetically engineered immunoglobulin, recover transformed cells, propagate, recover immunoglobulin |
| 08/08/2002 | US20020106378 Materials and methods for intracellular transport and their uses |
| 08/08/2002 | US20020106371 For therapy of sytematic lupus erythematosus, primary biliary cirrhosis, and idiopathic thrombocytopenic purpura |
| 08/08/2002 | US20020106370 Improvements in or relating to peptide delivery |
| 08/08/2002 | CA2437021A1 Adiponectin-associated protein |
| 08/08/2002 | CA2436503A1 Improved methods for protein identification, characterization and sequencing by tandem mass spectrometry |
| 08/08/2002 | CA2436092A1 Modified antibodies and methods of use |
| 08/08/2002 | CA2434953A1 Protein modification and maintenance molecules |
| 08/08/2002 | CA2432867A1 A novel human leucine-rich repeat containing protein expressed predominately in small intestine, hlrrsi1 |
| 08/08/2002 | CA2432731A1 A chimeric protein comprising non-toxic pseudomonas exotoxin a and type iv pilin sequences |
| 08/07/2002 | EP1229116A1 Method for preparing cell fraction containing hemangioblasts |
| 08/07/2002 | EP1229114A1 Gene encoding protein capable of regenerating luciferin, novel recombinant dna and process for producing protein capable of regenerating luciferin |
| 08/07/2002 | EP1229045A1 Universal carrier for targeting molecules to Gb3 receptor expressing cells |
| 08/07/2002 | EP1228768A1 Medicament for the protection against thrombotic diseases |
| 08/07/2002 | EP1228237A1 Expression vectors, transfection systems, and method of use thereof |
| 08/07/2002 | EP1228234A2 Production of chimeric capsid vectors |
| 08/07/2002 | EP1228214A2 Erythropoietin forms with improved properties |
| 08/07/2002 | EP1228212A2 Protein present at the surface of hematopoietic stem cells of the lymphoid line and of nk cells, and uses thereof |
| 08/07/2002 | EP1228210A2 Nuclear matrix proteins, polynucleotide sequences encoding them, and their use |
| 08/07/2002 | EP1228206A2 Compositions and methods for determining interactions of mitochondrial components, and for identifying agents that alter such interactions |
| 08/07/2002 | EP1228203A2 Peptide (virip) which inhibits a circulating virus in humans and the use thereof |
| 08/07/2002 | EP1228096A1 Dog and rabbit motilin receptor orthologs |
| 08/07/2002 | EP1228092A1 24 human secreted proteins |
| 08/07/2002 | EP1228088A2 Novel traf family proteins |
| 08/07/2002 | EP1228087A1 Antibody catalysis of enantio- and diastereo-selective aldol reactions |
| 08/07/2002 | EP1228086A1 PROCESS FOR CORRECTION OF A DISULFIDE MISFOLD IN Fc MOLECULES |
| 08/07/2002 | EP1228082A1 29 human secreted proteins |
| 08/07/2002 | EP1227833A1 Plasminogen-like polynucleotides, polypeptides, and antibodies |
| 08/07/2002 | EP1227736A1 Protein hydrolysates produced with the use of marine proteases |
| 08/07/2002 | EP1073763A4 Methods for transducing fusion molecules |
| 08/07/2002 | EP0809517B1 Anti-transforming growth factor-beta gene therapy |
| 08/07/2002 | EP0801649B1 Hydroxylamine derivatives useful for enhancing the molecular chaperon production and the preparation thereof |
| 08/07/2002 | EP0636183B1 Compositions and methods for protein structural determinations |
| 08/07/2002 | CN1362968A Novel peptides |
| 08/07/2002 | CN1362525A Small peptide heme and its prepn |
| 08/06/2002 | US6429303 Nucleic acids encoding members of the human B lymphocyte activation antigen B7 family and methods of using the same |
| 08/06/2002 | US6429295 Monoclonal antibody which recognizes the oligosaccharide N-glycolylated-galactose-glucose sialic acid in malignant tumors, and composition containing it |
| 08/06/2002 | US6429290 Modulation of body weight; diagnosis; dietetics; gene expression; drug screening |
| 08/06/2002 | US6429289 Class BI and CI scavenger receptors |
| 08/06/2002 | US6429188 Vasoactive intestinal peptide and peptide activating hypofissiary adenylate cyclase; inhibiting production of tumor necrosis factor and interleukin 6; amino acid seq id no:1, 2 and 3 |
| 08/06/2002 | US6429004 Transforming or transfecting a cell with a vector containing a polynucleotide which encodes a polypeptide having amidase activity useful for the production of optically active compounds |
| 08/06/2002 | US6428997 Aminopeptidase derived from Bacillus licheniformis and process for preparation of natural type proteins |
| 08/06/2002 | US6428990 Conversion of dihomo-gamma-linolenic acid to arachidonic acid and 20:4n-3 to eicosapentaenoic acid by host cell transformed to express human delta5-desaturase enzyme |
| 08/06/2002 | US6428980 Involved in cell cycle regulation for use in assays screening for cell cycle modulators and use as therapeutics for controlling apoptosis, cell proliferation, etc. in disease states or for wound healing |
| 08/06/2002 | US6428978 Producing gelatin and genuine telopeptide collagen in yeasts or other cells by coexpression of dna constructs encoding alpha1(i) and alpha2(i) collagen monomers lacking the c and/or n propeptides |
| 08/06/2002 | US6428977 Transforming growth factor-beta (tgf-beta); nucleic acid; polypeptide promotes the formation of ventral mesoderm in xenopus animal pole explants; use promoting osteogenesis for example |
| 08/06/2002 | US6428960 Inserting a puromycin resistance gene, adjacent to the baculovirus gene of interest and selecting for viruses that express the selectable marker |
| 08/06/2002 | US6428954 Method for identifying active domains and amino acid residues in polypeptides and hormone variants |
| 08/06/2002 | US6428792 Linear amino acid sequences from viral core, e1, e2, ns3, ns4, and ns5 regions; excellent sensitivity and specificity for immunoassay of antibodies; screening body fluids such as blood |
| 08/06/2002 | US6428789 Administering antigens obtained from dermatophytes to animals; innoculation; immunology |
| 08/06/2002 | CA2122714C Materials comprising and methods of preparation and use for ribosome-inactivating proteins |
| 08/06/2002 | CA2057010C Anti-idiotypic antibody which induces an immune response against a glycosphingolipid and use thereof |
| 08/06/2002 | CA1341381C Yeast hybrid vectors and their use for the production of polypeptides |
| 08/01/2002 | WO2002059613A2 Oomycete ftsz-mt as a target for antimicrobial-specific biocides |
| 08/01/2002 | WO2002059609A2 Methods of diagnosing colorectal cancer and/or breast cancer, compositions, and methods of screening for colorectal cancer and/or breast cancer modulators |
| 08/01/2002 | WO2002059604A2 Diagnosis and treatment of multiple sclerosis |
| 08/01/2002 | WO2002059340A1 Immunopolypeptides to hepatitis c virus |